Article written by Christine Clark. The long-awaited systematic review of ivermectin trials from Dr Tess Lawrie’s team at the Evidence-based Medicine Consultancy has now been published in the… read more.
Interview and article by Christine Clark. The anti-tumour effects of ivermectin have been described in the literature and the liposomal delivery system developed by Mountain Valley MD could… read more.
Interview and article by Christine Clark. Liposomal drug delivery holds out the prospect of oral drug administration without the need for water and more economical use of oral… read more.
Interview and article by Christine Clark. Patented solubilisation technology improves the bioavailability of oral ivermectin and makes possible the formulation of an ivermectin injection for human use, according… read more.
Reduced levels of a metabolic hormone known as leptin is linked to poor vaccine antibody responses in the general population, a University of Queensland study has found. The… read more.
Interview and article by Christine Clark. Steve Kirsch, CEO of the Covid-19 Early Treatment Fund (CETF) explains how a study in Nepal will advance our understanding of effective… read more.
Interview and article by Christine Clark. A combination of fluvoxamine and ivermectin for early treatment of covid-19 is highly effective and should be implemented widely, according to Steve… read more.
Article by Christine Clark. Evidence from trials and real world experience shows that selective serotonin reuptake inhibitors (SSRIs) are effective in treating acute covid and preventing long-haul covid.
Interview and article by Christine Clark. Early treatment of covid-19 with fluvoxamine has been remarkably effective in two trials, one of which was funded by the Covid-19 Early… read more.
People who have had mild illness develop antibody-producing cells that can last lifetime Washington University School of Medicine Months after recovering from mild cases of COVID-19, people still… read more.
Ad26.COV2-S [recombinant] a single-dose coronavirus vaccine from Janssen, part of Johnson & Johnson, has been approved by the MHRA (UK) and is indicated for active immunisation to prevent… read more.
Four months of multi-drug therapy that included rifapentine and moxifloxacin treated active tuberculosis (TB) as effectively as the standard six-month regimen in a multinational study, cutting treatment time… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
